Literature DB >> 24765430

Retinal arterial plaques in acquired immunodeficiency syndrome.

Pradeep Venkatesh1, Harish Pathak1, Satpal Garg1.   

Abstract

The authors report the unusual observation discrete plaque like excrescencies along the retinal arterial wall in a young patient with acquired immunodeficiency syndrome. Though bilateral, in the right eye there was severe arteriolar narrowing and so these plaques were less identifiable. Fluorescein angiography did not reveal any arteriolar occlusion or areas of capillary occlusion in both eyes. There were no other signs of HIV associated microangiopathy and the patient did not have any concurrent cardiovascular or hematological abnormality. The cause of these plaques remains unexplained and we conjecture that they could represent macro immune-complex deposition along the arteriolar walls.

Entities:  

Keywords:  AIDS; microangiopathy; retinal plaques.

Year:  2012        PMID: 24765430      PMCID: PMC3981290          DOI: 10.4081/cp.2012.e31

Source DB:  PubMed          Journal:  Clin Pract        ISSN: 2039-7275


  4 in total

1.  Retinal microvasculopathy and reduced cerebral blood flow in patients with acquired immunodeficiency syndrome.

Authors:  S A Geier; E Schielke; V Klauss; A Müller; K M Einhäupl; F D Goebel; K Tatsch
Journal:  Am J Ophthalmol       Date:  1992-01-15       Impact factor: 5.258

2.  Retinal vascular occlusion in patients infected with human immunodeficiency virus.

Authors:  James P Dunn; Andrea Yamashita; John H Kempen; Douglas A Jabs
Journal:  Retina       Date:  2005-09       Impact factor: 4.256

Review 3.  AIDS--an immunologic reevaluation.

Authors:  M Seligmann; L Chess; J L Fahey; A S Fauci; P J Lachmann; J L'Age-Stehr; J Ngu; A J Pinching; F S Rosen; T J Spira
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

4.  A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome.

Authors:  W R Freeman; C W Lerner; J A Mines; R S Lash; A J Nadel; M B Starr; M L Tapper
Journal:  Am J Ophthalmol       Date:  1984-02       Impact factor: 5.258

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.